Polymyalgia rheumatica occurring during treatment with ipilimumab

Eur J Dermatol. 2016 Oct 1;26(5):513-514. doi: 10.1684/ejd.2016.2837.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Humans
  • Ipilimumab
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Polymyalgia Rheumatica / chemically induced*
  • Polymyalgia Rheumatica / diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / secondary

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Ipilimumab